Related Experiment Videos
[Treatment of ulcus cruris. What is the role of wound dressings?]
1Abteilung Medizin der Paul Hartmann AG, Heidenheim/Brenz.
Medizinische Monatsschrift Fur Pharmazeuten
|December 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[Modern dressings. Hydrogels].
Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti·1995
[Foil bandages--a modern method of covering wounds].
Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti·1994
[The modern approach to dressing wounds].
Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti·1992
[Healing of a deep skin wound using a collagen sponge as dressing in the animal experiment].
Aktuelle Traumatologie·1992
[Is cooling harmful to wounds?].
Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti·1992
[Advantages of alginate bandages for coverage of extensive and poorly healing wounds].
Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti·1992
Zika virus infections.
Medizinische Monatsschrift fur Pharmazeuten·2018
Pitolisant for the treatment of narcolepsy with or without cataplexy.
Medizinische Monatsschrift fur Pharmazeuten·2018
Curses or blessings? Opioids in non cancer chronic pain.
Medizinische Monatsschrift fur Pharmazeuten·2018
The cancer patient’s soul.
Medizinische Monatsschrift fur Pharmazeuten·2018
The psoriasis patient – an exemplification of interdisciplinarity.
Medizinische Monatsschrift fur Pharmazeuten·2018
Management of psoriasis.
Medizinische Monatsschrift fur Pharmazeuten·2018
Time to Treatment Failure as a Recorded Treatment-Process Measure in C-CAT. Reply to Comment on "Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462".
Current oncology (Toronto, Ont.)·2026
Does Time to Treatment Failure Measure the Same Clinical Process Across Oncology Facilities? Comment on Kajiura et al. Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462.
Current oncology (Toronto, Ont.)·2026
[177Lu]Lu-PSMA-617 in Metastatic Hormone-Sensitive Prostate Cancer: Evidence from PSMAddition and Considerations for Treatment Sequencing.
Current oncology (Toronto, Ont.)·2026
A New Era of Treatment Sequencing in Platinum-Resistant Ovarian Cancer: Integrating Immunotherapy, Antibody-Drug Conjugates, and Targeted Therapies.
Current oncology (Toronto, Ont.)·2026